The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
Open accessAbstract
SUMMARY Epstein-Barr virus (EBV) represents a major global health problem. Though it is associated with infectious mononucleosis and over 200,000 cancers annually worldwide, a vaccine is not available. The major target of immunity is EBV glycoprotein 350/220 (gp350) that mediates attachment to B cells through complement receptor 2 (CR2/CD21). Here, we created self-assembling nanoparticles that displayed different domains of gp350 in a symmetric array. By focusing presentation of the CR2-binding domain on nanoparticles, potent neutralizing antibodies were elicited in mice and non-human primates. The structurally designed nanoparticle vaccine improved vaccine-induced protection in a mouse model by targeting a functionally conserved site of vulnerability with 10- to 100-fold increased neutralization compared to soluble gp350. This rational approach to EBV vaccine design elicited potent neutralizing antibody responses by focusing on a conserved viral entry domain, a strategy that can be applied to other viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Self-citationStructural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130
Self-citationEpstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A., & Fearon, D. T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4510 · Cited by 939
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Self-citationRational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 594
Magnetoferritin: in Vitro Synthesis of a Novel Magnetic Protein
Meldrum, F. C., Heywood, B. R., & Mann, S. (1992) · Science · doi:10.1126/science.1636086 · Cited by 572
Okuno, Y., Isegawa, Y., Sasao, F., & Ueda, S. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2552-2558.1993 · Cited by 489
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Ekiert, D. C., Kashyap, A. K., Steel, J., Rubrum, A., Bhabha, G., Khayat, R., Lee, J. H., Dillon, M. A., O’Neil, R. E., Faynboym, A. M., et al. (2012) · Nature · doi:10.1038/nature11414 · Cited by 481
Fusing structure and function: a structural view of the herpesvirus entry machinery
Connolly, S. A., Jackson, J. O., Jardetzky, T. S., & Longnecker, R. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2548 · Cited by 477
NEUTRALIZING ANTIVIRAL B CELL RESPONSES
Bachmann, M. F., & Zinkernagel, R. M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.235 · Cited by 471
Propagation and recovery of intact, infectious Epstein–Barr virus from prokaryotic to human cells
Delecluse, H.-J., Hilsendegen, T., Pich, D., Zeidler, R., & Hammerschmidt, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8245 · Cited by 467
Whittle, J. R. R., Zhang, R., Khurana, S., King, L. R., Manischewitz, J., Golding, H., Dormitzer, P. R., Haynes, B. F., Walter, E. B., Moody, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111497108 · Cited by 439
Self-citationSokal, E. M., Hoppenbrouwers, K., Vandermeulen, C., Moutschen, M., Léonard, P., Moreels, A., Haumont, M., Bollen, A., Smets, F., & Denis, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/523813 · Cited by 426
Structural basis of enzyme encapsulation into a bacterial nanocompartment
Sutter, M., Boehringer, D., Gutmann, S., Günther, S., Prangishvili, D., Loessner, M. J., Stetter, K. O., Weber-Ban, E., & Ban, N. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1473 · Cited by 411
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Cohen, J. I., Fauci, A. S., Varmus, H., & Nabel, G. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002878 · Cited by 381
Self-citationKhurana, S., Verma, N., Yewdell, J. W., Hilbert, A. K., Castellino, F., Lattanzi, M., Del Giudice, G., Rappuoli, R., & Golding, H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002336 · Cited by 356
Hutt-Fletcher, L. M. (2007) · Journal of Virology · doi:10.1128/jvi.00445-07 · Cited by 323
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
Tugizov, S. M., Berline, J. W., & Palefsky, J. M. (2003) · Nature Medicine · doi:10.1038/nm830 · Cited by 286
Structural and genetic basis for development of broadly neutralizing influenza antibodies
Lingwood, D., McTamney, P. M., Yassine, H. M., Whittle, J. R. R., Guo, X., Boyington, J. C., Wei, C.-J., & Nabel, G. J. (2012) · Nature · doi:10.1038/nature11371 · Cited by 268
Self-citationThe Role of Antibody Concentration and Avidity in Antiviral Protection
Bachmann, M. F., Kalinke, U., Althage, A., Freer, G., Burkhart, C., Roost, H.-P., Aguet, M., Hengartner, H., & Zinkernagel, R. M. (1997) · Science · doi:10.1126/science.276.5321.2024 · Cited by 267
Epstein, M. A., Morgan, A. J., Finerty, S., Randle, B. J., & Kirkwood, J. K. (1985) · Nature · doi:10.1038/318287a0 · Cited by 203
Combining Electron Microscopic with X-Ray Crystallographic Structures
Rossmann, M. G., Bernal, R., & Pletnev, S. V. (2001) · Journal of Structural Biology · doi:10.1006/jsbi.2002.4435 · Cited by 201
Self-citationRe-engineering protein interfaces yields copper-inducible ferritin cage assembly
Huard, D. J. E., Kane, K. M., & Tezcan, F. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1163 · Cited by 187
Selection of recombinant vaccinia viruses on the basis of plaque formation
Blasco, R., & Moss, B. (1995) · Gene · doi:10.1016/0378-1119(95)00149-z · Cited by 182
Lee, P. S., Yoshida, R., Ekiert, D. C., Sakai, N., Suzuki, Y., Takada, A., & Wilson, I. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212371109 · Cited by 179
van den Brink, E. N., ter Meulen, J., Cox, F., Jongeneelen, M. A. C., Thijsse, A., Throsby, M., Marissen, W. E., Rood, P. M. L., Bakker, A. B. H., Gelderblom, H. R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1635-1644.2005 · Cited by 159
Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
Ogembo, J. G., Kannan, L., Ghiran, I. C., Nicholson-Weller, A., Finberg, R. W., Tsokos, G. C., & Fingeroth, J. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.023 · Cited by 153
Phase I Trial of a CD8+T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis
Elliott, S. L., Suhrbier, A., Miles, J. J., Lawrence, G., Pye, S. J., Le, T. T., Rosenstengel, A., Nguyen, T. H., Allworth, A. M., Burrows, S. R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01409-07 · Cited by 151
Tanner, J. E., Whang, Y. E., Sample, J. T., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.12.4452-4464.1988 · Cited by 139
Trikha, J., Theil, E. C., & Allewell, N. M. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0274 · Cited by 132
Structure of the Epstein-Barr virus major envelope glycoprotein
Szakonyi, G., Klein, M. G., Hannan, J. P., Young, K. A., Ma, R. Z., Asokan, R., Holers, V. M., & Chen, X. S. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1161 · Cited by 119
Structural insights into key sites of vulnerability on HIV ‐1 Env and influenza HA
Julien, J., Lee, P. S., & Wilson, I. A. (2012) · Immunological Reviews · doi:10.1111/imr.12005 · Cited by 98
Krey, T., Meola, A., Keck, Z., Damier-Piolle, L., Foung, S. K. H., & Rey, F. A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003364 · Cited by 94
Sashihara, J., Burbelo, P. D., Savoldo, B., Pierson, T. C., & Cohen, J. I. (2009) · Virology · doi:10.1016/j.virol.2009.06.013 · Cited by 93
Self-citationCho, K. J., Shin, H. J., Lee, J.-H., Kim, K.-J., Park, S. S., Lee, Y., Lee, C., Park, S. S., & Kim, K. H. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.078 · Cited by 90
Structure of human ferritin L chain
Wang, Z., Li, C., Ellenburg, M., Soistman, E., Ruble, J. R., Wright, B., Ho, J. X., & Carter, D. C. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906018294 · Cited by 85
Cryo-EM of macromolecular assemblies at near-atomic resolution
Baker, M. L., Zhang, J., Ludtke, S. J., & Chiu, W. (2010) · Nature Protocols · doi:10.1038/nprot.2010.126 · Cited by 81
Chen, Z., Earl, P. L., Americo, J. L., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00906-07 · Cited by 73
Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor
Chen, Z., Fischer, E. R., Kouiavskaia, D. V., Hansen, B. T., Ludtke, S. J., Bidzhieva, B., Makiya, M. A., Agulto, L., Purcell, R. H., & Chumakov, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320041110 · Cited by 54
Structural basis for the antibody neutralization ofHerpes simplex virus
Lee, C., Lin, L., Chan, W.-E., Ko, T., Lai, J.-S., & Wang, A. H. ‐. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913016776 · Cited by 53
Young, K. A., Herbert, A. P., Barlow, P. N., Holers, V. M., & Hannan, J. P. (2008) · Journal of Virology · doi:10.1128/jvi.01673-08 · Cited by 53
Sashihara, J., Hoshino, Y., Bowman, J. J., Krogmann, T. A., Burbelo, P. D., Coffield, V. M., Kamrud, K. I., & Cohen, J. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002308 · Cited by 51
Self-citationAntibody Evasion by a Gammaherpesvirus O-Glycan Shield
Machiels, B., Lété, C., Guillaume, A., Mast, J., Stevenson, P. G., Vanderplasschen, A. F. C., & Gillet, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002387 · Cited by 46
Chen, Z., Chumakov, K., Dragunsky, E. M., Kouiavskaia, D. V., Makiya, M. A., Neverov, A., Rezapkin, G. V., Sebrell, A., & Purcell, R. H. (2011) · Journal of Virology · doi:10.1128/jvi.02553-10 · Cited by 46
Joyce, M. G., Kanekiyo, M., Xu, L., Biertümpfel, C., Boyington, J. C., Moquin, S. A., Shi, W., Wu, X., Yang, Y., Yang, Z., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02717-12 · Cited by 35
Self-citationElicitation of HIV-1-neutralizing antibodies against the CD4-binding site
Georgiev, I. S., Joyce, M. G., Zhou, T., & Kwong, P. D. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328363a90e · Cited by 32
Self-citationThe Structure and Host Entry of an Invertebrate Parvovirus
Meng, G., Zhang, X., Plevka, P., Yu, Q., Tijssen, P., & Rossmann, M. G. (2013) · Journal of Virology · doi:10.1128/jvi.01822-13 · Cited by 23
Self-citationHutt‐Fletcher, L. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0859-2_6 · Cited by 7
Cited by
Epstein–Barr virus: more than 50 years old and still providing surprises
Young, L. S., Yap, L. F., & Murray, P. G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.92 · Cited by 856
COVID-19 vaccine development and a potential nanomaterial path forward
Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., Wirth, D. M., Chen, A., Sack, M., Pokorski, J. K., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0737-y · Cited by 659
Farrell, P. J. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013023 · Cited by 541
Walls, A. C., Fiala, B., Schäfer, A., Wrenn, S., Pham, M. N., Murphy, M., Tse, L. V., Shehata, L., O’Connor, M. A., Chen, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.043 · Cited by 532
Huang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 490
Metadata
- Authors
- Kanekiyo, M., Bu, W., Joyce, M. G., Meng, G., Whittle, J. R. R., Baxa, U., Yamamoto, T., Narpala, S., Todd, J.-P., Rao, S. S., McDermott, A. B., Koup, R. A., Rossmann, M. G., Mascola, J. R., Graham, B. S., Cohen, J. I., & Nabel, G. J.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 162
- Issue
- 5
- Pages
- 1090-1100
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2162802735
- Cited by
- 366
- References
- 50
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.